{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:14:50Z","timestamp":1773400490239,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jcin.2023.05.040","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T14:39:30Z","timestamp":1688999970000},"page":"1679-1681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Optimal Management of Femoropopliteal Arterial Disease in Patients With Intermittent Claudication"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5131-3694","authenticated-orcid":false,"given":"Debabrata","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2023.05.040_bib1","first-page":"999","article-title":"Peripheral arterial disease: considerations in risks, diagnosis, and treatment","volume":"101","author":"Mukherjee","year":"2009","journal-title":"J\u00a0Natl Med Assoc"},{"key":"10.1016\/j.jcin.2023.05.040_bib2","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2023.05.040_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1055\/s-0031-1278244","article-title":"Peripheral arterial disease: epidemiology, natural history, diagnosis and treatment","volume":"16","author":"Dhaliwal","year":"2007","journal-title":"Int J Angiol"},{"key":"10.1016\/j.jcin.2023.05.040_bib4","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jacc.2016.11.007","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2023.05.040_bib5","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2174\/1570161114999160719104936","article-title":"Increased exercise favorably modifies coronary artery disease and peripheral arterial disease outcomes","volume":"14","author":"Whayne","year":"2016","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.jcin.2023.05.040_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2174\/1570161033476673","article-title":"Clinical perspectives on the role of anti-platelet and statin therapy in patients with vascular diseases","volume":"1","author":"Dey","year":"2003","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.jcin.2023.05.040_bib7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/1570161111311040014","article-title":"Current evidence for antithrombotic therapy after peripheral vascular interventions","volume":"11","author":"Saha","year":"2013","journal-title":"Curr Vasc Pharmacol"},{"issue":"13","key":"10.1016\/j.jcin.2023.05.040_bib8","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.jcin.2023.05.001","article-title":"Long-term patient outcomes after femoropopliteal peripheral vascular intervention in patients with intermittent claudication","volume":"16","author":"Altin","year":"2023","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2023.05.040_bib9","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jacc.2018.06.041","article-title":"Major adverse limb events and 1-year outcomes after peripheral artery revascularization","volume":"72","author":"Hess","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2023.05.040_bib10","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1161\/01.CIR.0000035649.39669.CE","article-title":"Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2)","volume":"106","author":"Mukherjee","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2023.05.040_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2023.05.040_bib12","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2023.05.040_bib13","doi-asserted-by":"crossref","first-page":"JC22","DOI":"10.7326\/ACPJ202008180-022","article-title":"After revascularization for PAD, rivaroxaban reduced vascular events with a small increase in major bleeding","volume":"173","author":"Mukherjee","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcin.2023.05.040_bib14","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879823009020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879823009020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:18:05Z","timestamp":1761848285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879823009020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":14,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1936879823009020"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2023.05.040","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal Management of Femoropopliteal Arterial Disease in Patients With Intermittent Claudication","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2023.05.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2023.05.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}